Atlas Trials

Study to Assess Dasatinib in Patients With Core Binding Factors Acute Myelogenous Leukemia

Clinical trial NCT02113319 · COMPLETED

Trial details

NCT number
NCT02113319
Sponsor
University Hospital, Angers
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myelogenous Leukemia
Start date
2007-04-01
Primary completion
2012-05-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.